André Lechel

13PUBLICATIONS
14CO-AUTHORS
Predictive and prognostic markersMolecular targetsChemotherapyHaematological tumoursCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Dec 15, 2025
CD44 upregulation in chronic liver disease marks the transition to hepatocellular carcinoma and portends poor prognosis.

Rui Dong, Akshaya Srikanth, Umesh Tharehalli

|Oct 31, 2025
Peptide-based inhibition of CD44v6 renders liver carcinomas more susceptible to therapeutic intervention.

Akshaya Srikanth, Ranjitha Vishnu Anand Rao, Rui Dong

|May 07, 2025
Cucurbitacin B Exhibits Antitumor Effects on Chordoma Cells via Disruption of Brachyury.

Carolin Seeling, Johannes Neumahr, Fabian Häberle

|Apr 11, 2025
Aberrant TERT expression: linking chronic inflammation to hepatocellular carcinoma†.

Rui Dong, Gregoire Najjar, Cagatay Günes

|Feb 15, 2022
CARD9 Forms an Alternative CBM Complex in Richter Syndrome.

Julia Maier, André Lechel, Ralf Marienfeld

|Apr 30, 2021
Iron at the Interface of Hepatocellular Carcinoma.

Rossana Paganoni, André Lechel, Maja Vujic Spasic

Pageof 3